CDR-404 is under clinical development by CDR-Life and currently in Phase I for Squamous Non-Small Cell Lung Cancer.
SON-1010 is under clinical development by Sonnet BioTherapeutics and currently in Phase I for Non-Small Cell Lung Cancer.
These survivors, or “cancer thrivers” as some of us prefer to say, helped show me that metastatic cancer is no longer a death sentence.
GlaxoSmithKline (GSK)’s B7-H3-targeted antibody-drug conjugate (ADC), GSK’227 has gained priority medicines (PRIME) ...
Sarcoma, a rare and often misunderstood cancer, affects the connective tissues of the body, such as bones, muscles, cartilage, etc. In contrast, more common cancers like breast, lung, and colon ...
Dec. 5, 2024 — Improvements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than treatment advances, according to a modeling study.
Lung cancer is one of the most common cancers. Stage 1 lung cancer is defined by tumors that are very small and have not spread (metastasized) to other parts of the body. Despite its name, it is ...
Like most cancer types, the chance of developing lung cancer increases with age. In the United States, lung cancer is most often diagnosed in people 65 or older. But lung cancer can occur at any age, ...
Nov. 6, 2024 — Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer. And devising ways to sense these compounds could help doctors ...
Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...
In addition to the ARTEMIS-001 study, HS-20093 is being investigated in multiple Phase I, II and III clinical trials across China for treating lung cancer, sarcoma, head and neck cancers ...
Our LUNG FORCE Heroes inspire, encourage and empower us to raise our voices for lung health. Read about their personal experiences with lung cancer, and become a LUNG FORCE Hero by sharing your story.